STUDY ON THE SITUATION, CLINICAL AND MICROBIOLOGICAL CHARACTERISTICS OF CELLULITIS IN PATIENTS WITH TYPE 2 DIABETES AT KIEN GIANG PROVINCE GENERAL HOSPITAL IN 2024

Van Da To1,, Van Tinh Huynh1, Van Phuong Vo2
1 Kien Giang Province General Hospital
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: The cellulitis is one of the complications in people with type 2 diabetes. If it was not treatmented on time, and it will progress more seriously, causing tissue necrosis in the damaged area, possibly causing sepsis and death. Objectives: 1. To determine the rate of cellulitis in patients with type 2 diabetes and several relevant factors of the cellulitis. 2. To describe the clinical and microbiological characteristics of the cellulitis in patients with type 2 diabetes. Materials and methods: The research of cross-sectional descriptive on 180 patients diagnosed with type 2 diabetes according to the Association Diabetic American guidelines in 2022. Results: The percentage of male was 35.0% and of female was 65.0%. The average age of pateints was 61.8 years old. The percentage of cellulitis in patients with type 2 diabetes was 13.9%. The average duration of illness of the patient was 8.6 years. The percentage of patients with comorbidities was 85.6%. The cellulitis location in the lower leg was largest contributor (32.0%) and the arm location was smallest contributor (0.8%). The percentage of positived bacterial culture was 76.0%. The Staphylococcus aureus (53.6%); the escherichia coli (15.8%). Conclusion: Most patients with diabetes of type 2 have comorbidities. The proportion of cellulitis was relatively large. The site of cellulitis in patients with diabetes of type 2 mainly in the lower legs and forearms. Most results of microbiological culture often were gram-positive bacteria.

Article Details

References

1. Nguyễn Thị Huỳnh, Hà Nguyễn Y Khuê và Đặng Nguyễn Đoan Trang. Khảo sát việc sử dụng kháng sinh trong điều trị nhiễm khuẩn da mô mềm tại Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh. Tạp chí y dược lâm sàng 108. 2021. 16 (DB11), 128-135, https://doi.org/10.52389/ydls.v0i0.873.
2. Zacay G, Hershkowitz Sikron F, Heymann AD. Glycemic Control and Risk of Cellulitis. Diabetes Care. 2021. 44(2), 367-372, https://doi.org/10.2337/dc19-1393.
3. Mor, Anil, and et al. Impact of glycemic control on risk of infections in patients with type 2 diabetes: a population-based cohort study. American journal of epidemiology. 2017. 186.2, 227236, https://doi.org/10.1093/aje/kwx049.
4. American Diabetes Association. Older Adults: Standards of Medical Care in Diabetes. Diabetes care. 2021. 44 (1), 168-179.38. https://doi.org/10.2337/dc21-S001.
5. Brindle, R., Williams, O. M., Barton, E., & Featherstone, P. Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis. JAMA dermatology. 2019. 155(9), 1033-1040, doi:10.1001/jamadermatol.2019.0884.
6. Phạm Thị Ánh Huy, Nguyễn Hải Thủy. Đánh giá tình trạng kiểm soát bệnh đái tháo đường theo khuyến cáo của hiệp hội đái tháo đường hoa kỳ trên bệnh nhân đái tháo đường típ 2 cao tuổi. Tạp chí Y Dược học Cần Thơ. 2023. số 58, 56-63, https://doi.org/10.58490/ctump.2023i58.694.
7. Mai Văn Điển. Khảo sát một số biến chứng mạch máu sớm ở bệnh nhân đái tháo đường type 2 tại Bệnh viện Thống Nhất - Đồng Nai. Tạp chí y học thực hành. 2011. (756) - 3/2011, 22-24.
8. Hoàng Thị Bình, Lê Bá Ngọc và Nguyễn Khoa Diệu Vân. Nhận xét đặc điểm tổn thương loét bàn chân và các yếu tố liên quan loét bàn chân ở bệnh nhân đái tháo đường điều trị tại Bệnh viện đa khoa tỉnh Hải Dương. Vietnam Journal of Diabetes and Endocrinology. 2023. (67), 89-96, https://doi.org/10.47122/VJDE.2023.67.13.
9. Võ Thị Ngọc Dung, Phùng Nguyên Quân, Trần Thị Ngọc Thanh. Khảo sát tình hình kiểm soát bệnh nhân đái tháo đường típ 2 tại bệnh viện đa khoa Sài Gòn thành phố Hồ Chí Minh. Tạp chí Nội tiết và Đái tháo đường. 2021. 46, 226-231, https://doi.org/10.47122/vjde.2021.46.25.
10.Dryden M, Baguneid M, Eckmann C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin Microbiol Infect. 2015. 21(Suppl. 2), S27–S32, https://doi.org/10.1016/j.cmi.2015.03.024. Lipsky, Benjamin A. et al. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials. International Journal of Infectious Diseases. 2015. 15.2, e140-e146, https://doi.org/10.1016/j.ijid.2010.10.003.
11.Falcone, Marco, et al. Diabetes and acute bacterial skin and skin structure infections. Diabetes research and clinical practice. 2021. 174, 108732, https://doi.org/10.1016/j.diabres.2021.108732.
12.Adimoolam, E., & Pitchai, R. Lower limb cellulitis in non-diabetic patients: a prospective study. International Surgery Journal. 2018. 5(6), 2339-2342, https://doi.org/10.18203/23492902.isj20182250.
13.Lakhundi S, Zhang K. Staphylococcus aureus methicillin. Molecular characterization, evolution, and epidemiology. Clinical microbiology reviews. 2018. 31.4, 10.1128/cmr. 00020-18, https://doi.org/10.1128/cmr.00020-18.